National Institute on Drug Abuse (NIDA): Amphetamine-Related Disorders trials

The registry lists 12 Amphetamine-Related Disorders studies with National Institute on Drug Abuse (NIDA) as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 7Phase 2 3Phase 4 1No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Phase 1 Parallel-Group, Double-Blind, Placebo-Controlled Cardiovascular and Behavioral Study Assessing Interactions Between Single Doses of Oral Reserpine and Intravenous Methamphetamine - 1Status unknownNCT00267657Phase 1
• Assessment of Interactions Between Intravenous Methamphetamine and Modafinil - 1Status unknownNCT00265278Phase 1
• To Assess the Safety and Tolerability of 7.5, 15 and 30 mg of Sublingual Lobeline. - 1Status unknownNCT00100074Phase 1
• Assessment of Interactions Between Methamphetamine and Aripiprazole - 1Status unknownNCT00089440Phase 1
• Bupropion for the Treatment of Methamphetamine Dependence - 1CompletedNCT00069251Phase 2
• Ondansetron for the Treatment of Methamphetamine Dependence - 1CompletedNCT00040053Phase 2
• Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1Status unknownNCT00040040Phase 1
• Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1Status unknownNCT00033072Phase 1
• Cognitive Correlates of Substance Abuse, Part 2 - 16Status unknownNCT00000351
• Effects of Stimulant Dependence on Human Striatal Dopamine System - 15Status unknownNCT00000350Phase 1
• Cognitive Correlates of Substance Abuse - 11Status unknownNCT00000346Phase 4
• Tyrosine for Methamphetamine Dependence - 1CompletedNCT00000322Phase 2